Immunology
-
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
This article has 8 authors:Reviewed by ScreenIT
-
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2
This article has 16 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response
This article has 25 authors:Reviewed by ScreenIT
-
Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants
This article has 32 authors:Reviewed by ScreenIT
-
Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein
This article has 11 authors:Reviewed by ScreenIT
-
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
This article has 52 authors:Reviewed by ScreenIT
-
Persistent serum protein signatures define an inflammatory subset of long COVID
This article has 20 authors:Reviewed by ScreenIT
-
Delayed antigen-specific CD4 + T-cell induction correlates with impaired immune responses to SARS-COV-2 mRNA vaccination in the elderly
This article has 12 authors:Reviewed by ScreenIT
-
Simultaneous and sequential multi-species coronavirus vaccination
This article has 12 authors:Reviewed by ScreenIT
-
Immunological findings in a group of individuals who were non-responders to standard two-dose SARS-CoV-2 vaccines
This article has 7 authors:Reviewed by ScreenIT